Menopur

Menotrophin, the active ingredient in Menopur, is a human menopausal gonadotropin presented as an injection solution for intramuscular and subcutaneous use. It treats infertility due to anovulation, supports controlled ovarian stimulation for assisted reproductive technology, and addresses hypogonadotropic hypogonadism.

GNH USA supplies Menopur as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Menopur (menotrophin) is employed in reproductive endocrinology to stimulate follicular development and ovulation.

- Infertility due to anovulation: induces ovulation and improves the chance of conception. - Controlled ovarian stimulation for assisted reproductive technology (e.g., IVF): promotes development of multiple follicles for egg retrieval. - Hypogonadotropic hypogonadism: provides necessary gonadotropins to initiate puberty and restore fertility.

Menopur may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Injection site pain or erythema: mild discomfort at the injection site. - Abdominal bloating or discomfort: transient abdominal fullness. - Nausea or vomiting: mild gastrointestinal upset. - Headache: occasional mild headache.

Serious or Rare Side Effects: - Ovarian hyperstimulation syndrome (severe): rapid ovarian enlargement with fluid shifts. - Multiple pregnancy: increased risk of twins or higher‑order gestations. - Ovarian torsion: acute pelvic pain due to twisted ovary. - Allergic reaction or anaphylaxis: rash, swelling, breathing difficulty.

Before initiating therapy, clinicians should consider several safety measures. - Monitor ovarian response: perform ultrasound and estradiol monitoring to avoid overstimulation. - Avoid use during pregnancy: discontinue if pregnancy occurs. - Use caution in patients with ovarian cysts or polycystic ovary syndrome: risk of excessive response. - Assess for hypersensitivity: discontinue if allergic reaction develops. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Menopur can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Other gonadotropins: may amplify ovarian response and raise OHSS risk. - Estrogen‑containing oral contraceptives: can reduce drug efficacy. - Anticoagulants: increase bleeding risk at injection sites.

Moderate Interactions (Monitor Closely): - NSAIDs: may worsen injection‑site pain. - Antihistamines: could mask early allergic signs. - Thyroid hormone therapy: thyroid status may affect ovarian response.